128 related articles for article (PubMed ID: 21269821)
21. Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma.
Pasello M; Michelacci F; Scionti I; Hattinger CM; Zuntini M; Caccuri AM; Scotlandi K; Picci P; Serra M
Cancer Res; 2008 Aug; 68(16):6661-8. PubMed ID: 18701490
[TBL] [Abstract][Full Text] [Related]
22. In Vitro and in Vivo Efficacy of NBDHEX on Gefitinib-resistant Human Non-small Cell Lung Cancer.
Sha H; Dong S; Yu C; Zou R; Zhu Y; Lu Y; Zhang J; Cao H; Chen D; Wu J; Feng J
J Cancer; 2020; 11(24):7216-7223. PubMed ID: 33193885
[TBL] [Abstract][Full Text] [Related]
23. Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and -resistant human osteosarcoma cell lines.
Sau A; Filomeni G; Pezzola S; D'Aguanno S; Tregno FP; Urbani A; Serra M; Pasello M; Picci P; Federici G; Caccuri AM
Mol Biosyst; 2012 Apr; 8(4):994-1006. PubMed ID: 22068640
[TBL] [Abstract][Full Text] [Related]
24. Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group.
Kaufmann R; Spieth K; Leiter U; Mauch C; von den Driesch P; Vogt T; Linse R; Tilgen W; Schadendorf D; Becker JC; Sebastian G; Krengel S; Kretschmer L; Garbe C; Dummer R;
J Clin Oncol; 2005 Dec; 23(35):9001-7. PubMed ID: 16260697
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
26. Discovery of 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol Derivatives as Glutathione Transferase Inhibitors with Favorable Selectivity and Tolerated Toxicity.
Liu Q; Liu Z; Hua W; Gou S
J Med Chem; 2021 Feb; 64(3):1701-1712. PubMed ID: 33529017
[TBL] [Abstract][Full Text] [Related]
27. Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro.
Ryabaya OO; Inshakov AN; Egorova AV; Emelyanova MA; Nasedkina TV; Zasedatelev AS; Khochenkov DA; Stepanova EV
Anticancer Drugs; 2017 Mar; 28(3):307-315. PubMed ID: 27941537
[TBL] [Abstract][Full Text] [Related]
28. Brain distribution and efficacy as chemosensitizer of an oral formulation of PARP-1 inhibitor GPI 15427 in experimental models of CNS tumors.
Tentori L; Leonetti C; Scarsella M; Vergati M; Xu W; Calvin D; Morgan L; Tang Z; Woznizk K; Alemu C; Hoover R; Lapidus R; Zhang J; Graziani G
Int J Oncol; 2005 Feb; 26(2):415-22. PubMed ID: 15645126
[TBL] [Abstract][Full Text] [Related]
29. 6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio) Hexanol Inhibits Proliferation and Induces Apoptosis of Endometriosis by Regulating Glutathione S-Transferase Mu Class 4.
Liu W; Cheng L; Du Y; Liu X; Ma J; Yan L
Reprod Sci; 2023 Oct; 30(10):2945-2961. PubMed ID: 36928896
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma.
Toshimitsu H; Yoshimoto Y; Augustine CK; Padussis JC; Yoo JS; Angelica Selim M; Pruitt SK; Friedman HS; Ali-Osman F; Tyler DS
Ann Surg Oncol; 2010 Aug; 17(8):2247-54. PubMed ID: 20182810
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of the combination of lomeguatrib and temozolomide compared with temozolomide alone in chemotherapy naive patients with metastatic cutaneous melanoma.
Ranson M; Hersey P; Thompson D; Beith J; McArthur GA; Haydon A; Davis ID; Kefford RF; Mortimer P; Harris PA; Baka S; Seebaran A; Sabharwal A; Watson AJ; Margison GP; Middleton MR
J Clin Oncol; 2007 Jun; 25(18):2540-5. PubMed ID: 17577032
[TBL] [Abstract][Full Text] [Related]
32. Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells.
Sciarretta F; Fulci C; Palumbo C; Rotili D; Tentori L; Graziani G; Caccuri AM
Chemotherapy; 2019; 64(3):138-145. PubMed ID: 31639786
[TBL] [Abstract][Full Text] [Related]
33. Glutathione S-transferase P1-1 as a target for mesothelioma treatment.
De Luca A; Pellizzari Tregno F; Sau A; Pastore A; Palumbo C; Alama A; Cicconi R; Federici G; Caccuri AM
Cancer Sci; 2013 Feb; 104(2):223-30. PubMed ID: 23121163
[TBL] [Abstract][Full Text] [Related]
34. Temozolomide and cisplatin in avdanced malignant melanoma.
Daponte A; Ascierto PA; Gravina A; Melucci M; Scala S; Ottaiano A; Simeone E; Palmieris G; Comella G
Anticancer Res; 2005; 25(2B):1441-7. PubMed ID: 15865103
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
[TBL] [Abstract][Full Text] [Related]
36. Temozolomide in combination with interferon alpha-2b in patients with metastatic melanoma: a phase I dose-escalation study.
Agarwala SS; Kirkwood JM
Cancer; 2003 Jan; 97(1):121-7. PubMed ID: 12491513
[TBL] [Abstract][Full Text] [Related]
37. The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo.
Palma JP; Rodriguez LE; Bontcheva-Diaz VD; Bouska JJ; Bukofzer G; Colon-Lopez M; Guan R; Jarvis K; Johnson EF; Klinghofer V; Liu X; Olson A; Saltarelli MJ; Shi Y; Stavropoulos JA; Zhu GD; Penning TD; Luo Y; Giranda VL; Rosenberg SH; Frost DJ; Donawho CK
Anticancer Res; 2008; 28(5A):2625-35. PubMed ID: 19035287
[TBL] [Abstract][Full Text] [Related]
38. Celastrol synergistically enhances temozolomide cytotoxicity in melanoma cells.
Chen M; Rose AE; Doudican N; Osman I; Orlow SJ
Mol Cancer Res; 2009 Dec; 7(12):1946-53. PubMed ID: 19934274
[TBL] [Abstract][Full Text] [Related]
39. Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.
Clemente N; Ferrara B; Gigliotti CL; Boggio E; Capucchio MT; Biasibetti E; Schiffer D; Mellai M; Annovazzi L; Cangemi L; Muntoni E; Miglio G; Dianzani U; Battaglia L; Dianzani C
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364157
[TBL] [Abstract][Full Text] [Related]
40. Effect of the STAT3 inhibitor STX-0119 on the proliferation of a temozolomide-resistant glioblastoma cell line.
Ashizawa T; Akiyama Y; Miyata H; Iizuka A; Komiyama M; Kume A; Omiya M; Sugino T; Asai A; Hayashi N; Mitsuya K; Nakasu Y; Yamaguchi K
Int J Oncol; 2014 Jul; 45(1):411-8. PubMed ID: 24820265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
